Journal of Cancer Research and Clinical Oncology

, Volume 139, Issue 8, pp 1303–1310 | Cite as

Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients

  • Francesca Bella
  • Pamela Minicozzi
  • Adriano Giacomin
  • Emanuele Crocetti
  • Massimo Federico
  • Maurizio Ponz de Leon
  • Mario Fusco
  • Rosario Tumino
  • Lucia Mangone
  • Orietta Giuliani
  • Mario Budroni
  • Milena Sant
Original Paper

Abstract

Purpose

Diabetes is associated with increased risk of developing colorectal cancer (CRC), but its effect on overall and cancer-specific mortality in CRC patients has been little investigated. The aim of this study was to assess the influence of diabetes on overall and cancer-specific mortality in Italian CRC patients.

Methods

Cases of adult (≥15 years) CRC, diagnosed in 2003–2005, most followed-up to the end of 2008, were randomly selected from the Italian Cancer Registries database. Diabetic status, sex, age, tumor stage, subsite, treatment, morphology, and grade were obtained by consultation of patient clinical records. Poisson multivariable regression models, adjusted for potential confounding variables, were used to estimate hazard ratios (HRs) for all-cause and CRC-specific mortality, according to diabetic status.

Results

A total of 1,039 CRC cases with known fasting glucose or diabetic status, archived in 7 cancer registries, was analyzed. Compared to non-diabetics, diabetics (specific diagnosis or glucose ≥126 mg/dl) were older and less likely to receive adjuvant therapy. Diabetics were at higher risk of all-cause death [HR 1.41; 95 % confidence interval (CI) 1.18–1.70] and CRC death (HR 1.36; 95 % CI 1.11–1.67), with no differences by sex or subsite.

Conclusions

Diabetes was significantly associated with increased overall and CRC-specific mortality. Our findings indicate that diabetes is a negative prognostic factor for CRC and suggest that in patients with CRC, diabetes prevention and treatments that stabilize the condition and control its complications might reduce mortality. Further studies are required to ascertain the mechanisms linking diabetes to greater mortality in CRC patients.

Keywords

Colorectal cancer Cancer-specific mortality Survival Diabetes Prognosis 

Notes

Acknowledgments

We thank the Compagnia di San Paolo, the Fondazione Cariplo, Italy and the Centro Nazionale per la Prevenzione e il Controllo delle Malattie of the Italian Ministry of Health for supporting this research; Chiara Margutti for secretarial assistance; Carlotta Buzzoni and AIRTUM for contributing to study design and providing data; and Don Ward for help with the English.

Conflict of interest

We declare that we have no conflict of interest.

References

  1. Agresti A (2002) Categorical data analysis, 2nd edn. Wiley, New YorkCrossRefGoogle Scholar
  2. AIRTUM Working Group, Crocetti E, Buzzoni C (2009) New incidence and mortality data 2003–2005. Epidemiol e Prev 33:e1–3–e5–26Google Scholar
  3. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J (Eds) (1995) Survival of cancer patients in Europe. The EUROCARE study. IARC Scientific Publication No 132. International Agency for Research on Cancer, LyonGoogle Scholar
  4. Booth GL, Kapral MK, Fung K, Tu JV (2006) Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368:29–36PubMedCrossRefGoogle Scholar
  5. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160–1167PubMedCrossRefGoogle Scholar
  6. De Marco MF, Janssen-Heijnen ML, van der Heijden LH, Coebergh JW (2000) Comorbidity and colorectal cancer according to subsite and stage: a population-based study. Eur J Cancer 36:95–99PubMedCrossRefGoogle Scholar
  7. Dehal AN, Newton CC, Jacobs EJ, Patel AV, Gapstur SM, Campbell PT (2012) Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the cancer prevention study-II nutrition cohort. J Clin Oncol 1:53–59. doi: 10.1200/JCO.2011.38.0303 CrossRefGoogle Scholar
  8. Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njølstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841. doi: 10.1056/NEJMoa1008862 CrossRefGoogle Scholar
  9. EUROCARE (2013) Survival of cancer patients in Europe. http://www.eurocare.it. Accessed 01 March 2013
  10. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781. doi: 10.1016/j.ejca.2009.12.014 PubMedCrossRefGoogle Scholar
  11. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin LH, Parkin MD, Whelan S (2000) International classification of disease for oncology (ICD-O), 3rd edn. World Health Organization, GenevaGoogle Scholar
  12. Gatta G, Ciccolallo L, Capocaccia R, Coleman MP, Hakulinen T, Møller H, Berrino F, EUROCARE Working Group (2003) Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer 39:2214–2222PubMedCrossRefGoogle Scholar
  13. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674–1685. doi: 10.2337/dc10-0666 PubMedCrossRefGoogle Scholar
  14. Gross CP, Guo Z, McAvay GJ, Allore HG, Young M, Tinetti ME (2006) Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc 54:1898–1904PubMedCrossRefGoogle Scholar
  15. Huang YC, Lin JK, Chen WS, Lin TC, Yang SH, Jiang JK, Chang SC, Lan YT, Wang HS, Liu CY, Yang YW, Teng HW (2011) Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol 137:211–220. doi: 10.1007/s00432-010-0879-7 PubMedCrossRefGoogle Scholar
  16. Jeon JY, Jeong DH, Park MG, Lee JW, Chu SH, Park JH, Lee MK, Sato K, Ligibel JA, Meyerhardt JA, Kim NK (2013) Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer. PLoS One 8:e55196. doi: 10.1371/journal.pone.0055196 PubMedCrossRefGoogle Scholar
  17. Jullumstrø E, Kollind M, Lydersen S, Edna TH (2009) Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol 48:361–367. doi: 10.1080/02841860802637765 PubMedCrossRefGoogle Scholar
  18. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRefGoogle Scholar
  19. Khandwala HM, McCutcheon IE, Flyvberg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215–244PubMedCrossRefGoogle Scholar
  20. Landriscina M, Esposito F (2011) Insulin resistant conditions: a favorable milieu for aggressive drug-resistant malignancies. J Gastrointest Oncol 2:11–12. doi: 10.3978/j.issn.2078-6891.2011.004 PubMedGoogle Scholar
  21. Lee L, Cheung WY, Atkinson E, Krzyzanowska MK (2011) Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol 29:106–117. doi: 10.1200/JCO.2010.31.3049 PubMedCrossRefGoogle Scholar
  22. Lemmens VE, Janssen-Heijnen ML, Houterman S, Verheij KD, Martijn H, van de Poll-Franse L, Coebergh JW (2007) Which comorbid conditions predict complications after surgery for colorectal cancer? World J Surg 31:192–199PubMedCrossRefGoogle Scholar
  23. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS (2003) Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 21:433–440PubMedCrossRefGoogle Scholar
  24. Park SM, Lim MK, Shin SA, Yun YH (2006) Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: national Health Insurance Corporation Study. J Clin Oncol 24:5017–5024PubMedCrossRefGoogle Scholar
  25. Polednak AP (2006) Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev 30:466–472PubMedCrossRefGoogle Scholar
  26. Pollak M (2008) Insulin and insulin-like growth factor signaling in neoplasia. Nat Rev Cancer 8:915–928PubMedCrossRefGoogle Scholar
  27. Roncucci L, Fante R, Losi L, Di Gregorio C, Micheli A, Benatti P, Madenis N, Ganazzi D, Cassinadri MT, Lauriola P, Ponz de Leon M (1996) Survival for colon and rectal cancer in a population-based cancer registry. Eur J Cancer 32:295–302CrossRefGoogle Scholar
  28. Schrag D, Cramer LD, Bach PB, Begg CB (2001) Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 93:850–857PubMedCrossRefGoogle Scholar
  29. Shonka NA, Anderson JR, Panwalkar AW, Reed EC, Steen PD, Ganti AK (2006) Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol 23:515–519PubMedCrossRefGoogle Scholar
  30. Sobin LH, Wittekind CH (2002) Colon and rectum. In: Sobin LH, Wittekind CH (eds) Classification of malignant tumours, 6th edn. Wiley-Liss, Geneva, pp 72–76Google Scholar
  31. StataCorp: Stata Statistical Software: Release 9 (2005) StataCorp LP. College Station, TXGoogle Scholar
  32. Thomas RM, Sobin LH (1995) Gastrointestinal cancer. Cancer 75:154–170PubMedCrossRefGoogle Scholar
  33. van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120:1986–1992PubMedCrossRefGoogle Scholar
  34. van de Poll-Franse LV, Haak HR, Coebergh JW, Janssen-Heijnen ML, Lemmens VE (2012) Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia 55:2163–2172. doi: 10.1007/s00125-012-2555-8 PubMedCrossRefGoogle Scholar
  35. Vrieling A, Kampman E (2010) The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr 92:471–490. doi: 10.3945/ajcn.2010.29005 PubMedGoogle Scholar
  36. Will JC, Galuska DA, Vinicor F, Calle EE (1998) Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 147:816–825PubMedCrossRefGoogle Scholar
  37. Woodward M, Zhang X, Barzi F, Pan W, Ueshima H, Rodgers A, MacMahon S, Asia Pacific Cohort Studies Collaboration (2003) The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 26:360–366PubMedCrossRefGoogle Scholar
  38. World Health Organization (2004) International classification of diseases (ICD) 10th revision, 2nd edn. World Health Organization, GenevaGoogle Scholar
  39. World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglicaemia report of aWHO/IDF consultation. World Health Organization, GenevaGoogle Scholar
  40. Yancik R, Wesley MN, Ries LA, Havlik RJ, Long S, Edwards BK, Yates JW (1998) Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer 82:2123–2134PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Francesca Bella
    • 1
  • Pamela Minicozzi
    • 1
  • Adriano Giacomin
    • 2
  • Emanuele Crocetti
    • 3
  • Massimo Federico
    • 4
  • Maurizio Ponz de Leon
    • 5
  • Mario Fusco
    • 6
  • Rosario Tumino
    • 7
  • Lucia Mangone
    • 8
  • Orietta Giuliani
    • 9
  • Mario Budroni
    • 10
  • Milena Sant
    • 1
  1. 1.Analytical Epidemiology and Health Impact Unit, Department of Preventive and Predictive MedicineFondazione IRCCS Istituto Nazionale dei TumoriMilanItaly
  2. 2.Piedmont Cancer RegistryProvince of Biella (CPO), Epidemiology UnitBiellaItaly
  3. 3.Tuscany Cancer RegistryClinical and Descriptive Epidemiology Unit, ISPOFlorenceItaly
  4. 4.Modena Cancer Registry, Department of Oncology, Hematology and Respiratory DiseasesUniversity of Modena and Reggio EmiliaModenaItaly
  5. 5.Division of Internal Medicine, Department of Internal Medicine and Specialized Colorectal Cancer RegistryUniversity of Modena and Reggio EmiliaModenaItaly
  6. 6.Campania Cancer RegistryLocal Health Unit Napoli 3, SouthBrusciano, NapoliItaly
  7. 7.Cancer Registry and Histopathology Unit, MP Arezzo Civic HospitalProvincial Health UnitRagusaItaly
  8. 8.Statistical, Quality and Clinical Studies UnitIRCCS Arcispedale Santa Maria NuovaReggio EmiliaItaly
  9. 9.Romagna Cancer RegistryIRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei TumoriMeldola, ForlìItaly
  10. 10.Sassari Cancer RegistryEpidemiology Unit, Local Health Unit 1SassariItaly

Personalised recommendations